Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Behind the Breakthroughs

  • Join the discussion with leading physician-scientists to learn how Dana-Farber's advancements in cancer research and care are possible because of your support.

  • Past Programs

    Click below to view each recording.

  • The Vital Work of Clinical Research Nurses

    Clinical Research Nurses (CRNs) are essential to the lifesaving research that takes place at Dana-Farber Cancer Institute. CRNs provide extraordinary care to patients participating in clinical trials, improving their experiences and outcomes through evidence-based research. Listen to Dana-Farber’s Anne Gross, PhD, RN, Kristen Legor, PhD, JD, RN, OCN, and Melissa Hohos, RN, BSN, OCN in a conversation about Dana-Farber’s CRN program and the positive impact it has on our patients and their families.

    Listen Now

  • CSO Forum:
    What is Epigenetics and How is it Transforming Cancer Therapies?

    For decades, cancer research has focused on the role of genetic mutations, or changes in the DNA sequence, in driving cancer. But DNA sequence is only part of the story. Like mutations in genes, epigenetic changes can also cause cancer. Epigenetics refers to changes in how genetic material is packaged and read by the cell, rather than changes to the DNA itself. We now know these changes can be reversed, opening the door to a new class of cancer-fighting drugs.

    Dana-Farber’s Chief Scientific Officer Kevin Haigis, PhD, speaks with Bradley Bernstein, MD, PhD, and Cigall Kadoch, PhD, about the revolutionary science of epigenetics. During their discussion, you will learn how applying epigenetic mechanisms has the potential to inform new treatments in both children and adults with cancer.

    Listen Now

  • The Promise Study:
    How a Blood Test Can Detect, Intercept, and Potentially Eliminate Cancer

    To significantly reduce the burden of cancer, we must advance our ability to detect and prevent cancers and their precursor conditions at their earliest stages. Watch this video featuring Dana-Farber’s Irene Ghobrial, MD, lead investigator on The Promise Study, to learn how this groundbreaking research initiative is screening those at high risk for multiple myeloma early in order to identify ways to stop cancer before it starts.

    Listen Now

  • Personal Cancer Vaccines: Customized Treatment for Each Patient

    At Dana-Farber, we are determined to Defy Cancer by finding solutions for every patient. Watch this video featuring Patrick Ott, MD, PhD, and Catherine Wu, MD, in a conversation about the revolutionary science of therapeutic vaccines tailored to each patient’s specific cancer. Learn about Dana-Farber’s progress in developing effective cancer vaccines through clinical trials and correlative research.

    Listen Now

  • Improving the Experience of Living with Cancer

    Watch this video featuring James Tulsky, MD, Chair of Dana-Farber’s Department of Psychosocial Oncology and Palliative Care, and Saj-nicole Joni, PhD, Dana-Farber donor, author, and global CEO advisor, about how Dana-Farber is defying cancer by integrating compassionate supportive care with industry-leading research to provide the best symptom management for today while developing innovative care models for the future.

    Listen Now

  • CSO Forum

    The Future of Precision Medicine:
    Delivering the Right Care at the Right Time

    View a virtual panel discussion led by Dana-Farber Cancer Institute's Chief Scientific Officer, Kevin Haigis, PhD, on the revolutionary science and promising future of precision cancer medicine. Hear from Dana-Farber experts on this transformative approach to cancer care and learn about the research being done to expand access for more individuals.

    Listen Now

  • Equity in Cancer Care

    Watch this video featuring Christopher Lathan, MD, MS, MPH, Director of Cancer Care Equity at Dana-Farber Cancer Institute; Nadine McCleary, MD, MPH, Gastrointestinal Oncologist at Dana-Farber Cancer Institute; and Sandra Stratford, MD, MSc, Dana-Farber Trustee and Co-Chair of Community Programs to learn about Dana-Farber's efforts to promote equity in clinical care and inclusive representation in cancer trials.

    Listen Now

  • Advancing Cancer Therapeutics

    Watch this video featuring Benjamin Ebert, MD, PhD, Chair, Department of Medical Oncology at Dana-Farber Cancer Institute, and Leena Gandhi, MD, PhD, Director, Center for Cancer Therapeutic Innovation at Dana-Farber Cancer Institute to to learn how Dana-Farber is maximizing its position as a leader in drug development to advance cancer therapeutics. They discuss how Dana-Farber’s Center for Cancer Therapeutic Innovation is advancing early-stage clinical trials and related research that serves as a beacon of hope for patients and their families.

    Listen Now

  • Intercepting Cancer

    Watch this video featuring Sapna Syngal, MD, MPH, Director of Research in the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, to learn how precision prevention, a Dana-Farber priority, is changing the course of cancer. She discusses hereditary cancers, the implications of genetic testing, and the promise of new early detection strategies. We encourage you to share this recording with your network.

    Listen Now

  • Light on the Horizon: COVID-19 Vaccines

    Watch this video featuring Dana-Farber's President and CEO, Dr. Laurie H. Glimcher, and Chief Operating Officer, Dr. William Hahn, to learn about the science behind the recently approved COVID-19 vaccine. We encourage you to share this recording with your network.

    Listen Now

  • Pediatric Past 1202

    Childhood leukemia was a universally fatal disease in the 1940s. From the first use of chemotherapy in the treatment of childhood leukemia in 1947 to today's 5-year cure rate of 90 percent, Stephen E. Sallan, MD, the Quick Family Chair in Pediatric Oncology at Dana-Farber, will walk us through the revolutionary breakthroughs forged by Dana-Farber and others to combat pediatric leukemia. Join us for an inspiring conversation with Dr. Sallan and Dr. Scott Armstrong, President of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, to learn about how leading physician-scientists have transformed the groundbreaking discoveries made by founder Dr. Sidney Farber, and where the field is headed to continue improving survival rates and quality of life for all children with cancer.

  • CSO Forum Past

    Tune in to a conversation with Dana-Farber's Chief Scientific Officer William C. Hahn, MD, PhD, and Vice Chair of Pediatric Oncology Research Kimberly Stegmaier, MD, to discuss the latest advances in treating childhood cancers. This conversation featured patient stories that highlight how Dana-Farber's research is addressing new challenges and providing hope for pediatric patients and their families everywhere.

  • Patient Assistance Past

    Learn about the resources Dana-Farber provides to patients and families from representatives of our Pediatric and Adult Patient Resource Programs. Now more than ever, Dana-Farber remains committed to helping reduce the burden of cancer.

  • Community Benefits Past

    Learn how Dana-Farber is delivering expert cancer care and screening directly to underserved populations to disrupt disparities and enhance the health of our community.

  • Telehealth Past

    Join the conversation to understand how Dana-Farber delivered as many as 3,000 telemedicine visits per week in immediate response to the pandemic and continues to lead in this area for patients. Hear directly from Dana-Farber’s expert physician-scientists about virtual visits, ethical and legislative factors, and where we go from here.

  • Count Me In Past

    Count Me In is a research initiative pursuing an innovative, patient-partnered approach to cancer research. Hear from Dana-Farber Cancer Institute’s Nikhil Wagle, MD, Director of Count Me In, to learn how this initiative is bringing patients and researchers together as partners to accelerate discoveries — allowing cancer patients anywhere in the United States or Canada to safely and easily share their medical information, personal experience, and tumor samples for genetic analysis, propelling progress against cancer.

  • exercise and nutrition past

    Learn how Dana-Farber's physician-scientists are combining groundbreaking discovery science research with clinical studies to understand the role of exercise in cancer prevention and treatment.

  • pop sci past

    In this webinar, you will hear about the innovative work of the Division of Population Science which spans numerous cancer disciplines including innovations in early cancer detection technology using sensitive blood biopsies, the application of molecular data to model cancer risk, interventions to promote patient health through tailored exercise programs, and DFCI’s approach to understanding the effects of COVID-19 on cancer care.

  • Red Sox Past

    A conversation with Red Sox executives, Sam Kennedy and Larry Lucchino, and Dana-Farber physician, Lisa Diller, to discuss the history of the 67-year long relationship between the Jimmy Fund and the Red Sox and its impact on pediatric patients in Dana-Farber’s Jimmy Fund Clinic.

  • immunocompromised past

    Hear from Paul Richardson, MD, as he discusses living with and caring for immunocompromised patients in the COVID-19 era.

  • Survivorship Past

    Led by Dana-Farber’s survivorship experts, learn about our commitment to fulfilling the unique physical and psychosocial needs of patients after a cancer diagnosis, and hear the inspiring stories of survivors.

  • AI Past

    Learn how Dana-Farber physician-scientists are harnessing the power of data to predict patient outcomes faster and more proactively than ever before.

  • Childhood Cancer Past

    Learn about how pediatric cancer research at Dana-Farber is aiding the fight against COVID-19 and how we are adapting the patient experience to continue to provide the best care for children with cancer.

  • Collaborating in Cancer_Past

    Learn how seven institutions across Boston are coming together to advance treatments for cancer patients.

  • Nurses Week_Past

    The World Health Organization has named 2020 the Year of the Nurse. Join us during National Nurses Week to learn how Dana-Farber is transforming the practice of nursing in the midst of a global pandemic, while cultivating the next generation of oncology nurses.

  • BC Prevention Past

    Learn how leaders of the Susan F. Smith Center for Women’s Cancers are mitigating risk and minimizing recurrence for breast cancer patients.

  • Steven Corsello MD

    Learn how Dr. Steven Corsello is testing thousands of non-oncology drugs for their potential to treat cancer.

  • 0430 Recording

    Learn how Dana-Farber is discovering ways to detect cancer more quickly and identify, monitor, and support those at greatest risk.

  • 4 - metastatic

    Leaders of the Susan F. Smith Center for Women’s Cancers share updates on their groundbreaking work in metastatic breast cancer and how this work is providing new treatments for breast cancer patients.

  • 5 - Breast Immuno

    Leaders of the Susan F. Smith Center for Women’s Cancers share updates on their groundbreaking work in immunotherapies and how this work is providing new treatments for breast cancer patients.

  • Top

    Leaders of Dana-Farber Cancer Institute share updates on our efforts to keep our patients, faculty, and staff safe as we remain undeterred from our mission to provide expert compassionate cancer care and research.

  • 7 - CSO Recording

    Hear how William G. Kaelin Jr., MD, a researcher at Dana-Farber, won the 2019 Nobel Prize for discoveries of how cells sense and adapt to oxygen availability. Dr. Kaelin discusses how these findings have led to new therapeutics for a wide range of disorders, including cancer.